NCT07359040 2026-03-12
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
Peking University People's Hospital
Active not recruiting
Clinical Trials
20 trialsNCT07466225 2026-03-12
HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion
Peking University
Not yet recruiting
NCT07466238 2026-03-12
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer
Peking University
Not yet recruiting
NCT07457099 2026-03-09
Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
Zhujiang Hospital
Not yet recruiting
NCT07453342 2026-03-06
Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
Peking Union Medical College Hospital
Recruiting
NCT07434518 2026-02-25
A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting
NCT04913311 2026-02-19
Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Recruiting
NCT07389876 2026-02-05
G/GEJ
Fudan University
Recruiting
NCT06283238 2026-01-29
Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)
Duke University
Withdrawn
NCT07249060 2025-12-03
INTER-AUTENTIC
Hospital Universitario Araba
Recruiting
NCT07100405 2025-08-17
TASK-01-RW
Fudan University
Recruiting
NCT06980350 2025-07-29
Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy
Sun Yat-sen University
Completed
NCT05486650 2025-07-14
An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment
Xinqiao Hospital of Chongqing
Recruiting
NCT07036016 2025-06-25
Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Completed
NCT07009600 2025-06-06
Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer
Samsung Medical Center
Completed
NCT04977791 2025-05-22
Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer
Shanghai Chest Hospital
Recruiting
NCT03868046 2025-04-01
AUTENTIC
Hospital Universitario Araba
Completed
NCT06900686 2025-03-28
Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival
Sun Yat-sen University
Completed
NCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
NCT06889402 2025-03-21
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting